Efficacy and safety of paromomycin for treating amebiasis in Japan

Parasitology International

Volumn 62, Issue 6, 2013, Pages 497-501

  Kikuchi, Tadashi ^a   Koga, Michiko ^a   Shimizu, Shoichi ^a   Miura, Toshiyuki ^a   Maruyama, Haruhiko ^b   Kimura, Mikio ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c FUKUJUJI HOSPITAL   (Japan)

Author keywords

Amebiasis; Luminal agent; Paromomycin; The Japanese Research Group on Chemotherapy of Tropical Diseases

Indexed keywords

METRONIDAZOLE; PAROMOMYCIN; ANTIAMEBIC AGENT;

ADULT; AMEBIASIS; ANOREXIA; ANTIMICROBIAL THERAPY; ARTICLE; BLOATING; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FLATULENCE; HEARTBURN; HUMAN; HYPERTRANSAMINASEMIA; JAPAN; LIVER AMEBIASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RECTUM HEMORRHAGE; ANIMAL; DRUG EFFECTS; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; INCIDENCE; LIVER ABSCESS, AMEBIC; MIDDLE AGED; PARASITOLOGY; TREATMENT OUTCOME;

CLOSTRIDIUM DIFFICILE; HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; AMEBIASIS; AMEBICIDES; ANIMALS; DIARRHEA; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; FEMALE; HUMANS; INCIDENCE; JAPAN; LIVER ABSCESS, AMEBIC; MALE; METRONIDAZOLE; MIDDLE AGED; PAROMOMYCIN; TREATMENT OUTCOME;

EID: 84885335181     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2013.07.004     Document Type: Article

References (27)

1. Haque R., Huston C.D., Hughes M., Houpt E., Petri W.A. Amebiasis. The New England Journal of Medicine 2003, 348:1565-1573.
2. Mandell G.L., Bennett J.E., Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 2010, Churchill Livingstone/Elsevier, Philadelphia. 7th ed.
3. Longo D.L., Harrison T.R. Harrison's principles of internal medicine 2012, McGraw-Hill, New York. 18th ed.
4. Freedman D.O., Weld L.H., Kozarsky P.E., Fisk T., Robins R., von Sonnenburg F., et al. Spectrum of disease and relation to place of exposure among ill returned travelers. The New England Journal of Medicine 2006, 354:119-130.
5. Taniguchi K., Yoshida M., Sunagawa T., Tada Y., Okabe N. Imported infectious diseases and surveillance in Japan. Travel Medicine and Infectious Disease 2008, 6:349-354.
6. Takeuchi T., Okuzawa E., Nozaki T., Kobayashi S., Mizokami M., Minoshima N., et al. High seropositivity of Japanese homosexual men for amebic infection. Journal of Infectious Diseases 1989, 159:808.
7. Ohnishi K., Murata M., Okuzawa E. Symptomatic amebic colitis in a Japanese homosexual AIDS patient. Internal Medicine 1994, 33:120-122.
8. Nagata N., Shimbo T., Akiyama J., Nakashima R., Nishimura S., Yada T., et al. Risk factors for intestinal invasive amebiasis in Japan, 2003-2009. Emerging Infectious Diseases 2012, 18:717-724.
9. Ishioka H., Umezawa M., Hatakeyama S. Fulminant amebic colitis in an HIV-infected homosexual man. Internal Medicine 2011, 50:2851-2854.
10. Ohnishi K., Uchiyama-Nakamura F. Metronidazole treatment for acute phase amoebic liver abscess in patients co-infected with HIV. International Journal of STD and AIDS 2012, 23:e1-e3.
11. Gonzales M.L., Dans L.F., Martinez E.G. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 2009, CD006085.
12. World Health Organization WHO model prescribing information: drugs used in parasitic diseases 1995, World Health Organization, Geneva. 2nd ed.
13. Stanley S.L. Amoebiasis. Lancet 2003, 361:1025-1034.
14. Hitani A., Nakamura T., Ohtomo H., Nawa Y., Kimura M. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan. Journal of Infection and Chemotherapy 2006, 12:277-282.
15. Kimura M., Koga M., Kikuchi T., Miura T., Maruyama H. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: The second report from the research group. Parasitology International 2012, 61:466-469.
16. WHO Amoebiasis. Weekly Epidemiological Record 1997, 72:97-99.
17. Kojima S., Uchikawa K., Kaji R., Takeuchi S. Diphyllobothriasis with special reference to treatment with paromomycin sulfate and bithionol [Article in Japanese]. Shinshu Igaku Zasshi 1982, 30:461-466.
18. Yazaki S., Takeuchi S., Maejima J., Fukumoto S., Kamo H., Sakaguchi Y. Efficacy of paromomycin sulfate in the elimination of Diphyllobothrium species and Taenia saginata in clinical cases [Article in Japanese]. The Japanese Journal of Antibiotics 1983, 36:638-643.
19. Hayashi S., Kamo H. Studies on the effect and the mode of action of paromomycin sulfate against tapeworm [Article in Japanese]. The Japanese Journal of Antibiotics 1983, 36:552-565.
20. Wagner E.D. Paromomycin in the treatment of amebiasis in Ethiopia. Antibiotic Medicine & Clinical Therapy 1960, 7:613-617.
21. Simon M., Shookhoff H.B., Terner H., Weingarten B., Parker J.G. Paromomycin in the treatment of intestinal amebiasis; a short course of therapy. American Journal of Gastroenterology 1967, 48:504-511.
22. Sullam P.M., Slutkin G., Gottlieb A.B., Mills J. Paromomycin therapy of endemic amebiasis in homosexual men. Sexually Transmitted Diseases 1986, 13:151-155.
23. Pamba H.O., Estambale B.B., Chunge C.N., Donno L. Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya. European Journal of Clinical Pharmacology 1990, 39:353-357.
24. Blessmann J., Tannich E. Treatment of asymptomatic intestinal Entamoeba histolytica infection. The New England Journal of Medicine 2002, 347:1384.
25. Watanabe K., Gatanaga H., Escueta-de Cadiz A., Tanuma J., Nozaki T., Oka S. Amebiasis in HIV-1-infected Japanese men: clinical features and response to therapy. PLoS Neglected Tropical Diseases 2011, 5:e1318.
26. Gardner T.B., Hill D.R. Treatment of giardiasis. Clinical Microbiology Reviews 2001, 14:114-128.
27. Danziger L.H., Kanyok T.P., Novak R.M. Treatment of cryptosporidial diarrhea in an AIDS patient with paromomycin. The Annals of Pharmacotherapy 1993, 27:1460-1462.